SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-042653
Filing Date
2018-06-28
Accepted
2018-06-28 06:01:27
Documents
4
Period of Report
2018-06-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-16093_18k.htm 8-K 76943
2 EX-3.1 a18-16093_1ex3d1.htm EX-3.1 134112
3 EX-10.1 a18-16093_1ex10d1.htm EX-10.1 158557
4 EX-10.2 a18-16093_1ex10d2.htm EX-10.2 1389342
  Complete submission text file 0001104659-18-042653.txt   1760533
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26301 | Film No.: 18923134
SIC: 2834 Pharmaceutical Preparations